Custom service
Peptide Library Design
Design peptide libraries with controlled diversity and tractable deconvolution
The service is built around position-wise diversity planning. Depending on the molecule we may move to Trp/Ox/Met-free degeneracy strategies or focused and saturation designs to improve stability, loading or yield, and every batch is released with library design document with synthesis plan.
Because Peptide Library Design projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Epitope mapping and SAR matrices
Libraries sized to the screening capacity available
Libraries whose deconvolution strategy is undefined
Sequences where a recombinant expression route is objectively cheaper and faster
Release specification is fixed at quotation: standard >95% by HPLC, >98% for assay-critical material. Long chains (>60 residues) are additionally confirmed by MS/MS sequence coverage, and truncated-deletion species are quantified, not just summarized.
Service Highlights
- Position-wise diversity planning as the default route, with Trp/Ox/Met-free degeneracy strategies held as a proven fallback
- Focused and saturation designs worked into the design where the application requires it
- Sequence difficulty analysis (aggregation risk, motif hazards) is done before synthesis, and the route is chosen around it
- Analytical confirmation of every intermediate before the final release
- Microwave-assisted coupling and double-coupling are applied automatically where the sequence demands them
- Library design document with synthesis plan delivered with a complete conjugation or synthesis certificate
How the work runs
Sequence analysis
Peptide Library Design is analyzed for aggregation risk, motif hazards and puri?cation difficulty before a route is quoted.
Route selection
Fmoc solid-phase, fragment ligation or hybrid solution-phase is selected and documented.
Assembly
The chain is built with position-wise diversity planning applied where the sequence demands it, with double-coupling at hazard sites.
Cleavage & crude QC
Crude material is characterized so purification targets are set on data, not hope.
Purification
RP-HPLC (and ion-exchange where needed) delivers the agreed purity; fractions are pooled on MS confirmation.
Release
Library design document with synthesis plan is documented with the full analytical package and released.
Specifications & timeline
- Turnaround
- 2–4 weeks
- Typical scale
- 0.1 mg – 10 g per sequence
- Chemistry options
- position-wise diversity planning; Trp/Ox/Met-free degeneracy strategies; focused and saturation designs
- Deliverable
- Library design document with synthesis plan
- QC package
- HPLC purity, ESI/MALDI MS, MS/MS confirmation for long chains
- Shipping
- Ambient with desiccant; blue ice for modified or sensitive peptides
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.